Willy Michel

Wilhelm Michel founded TecMed AG in 2020, Disetronic Holding AG in 1984, where he worked as Chairman & General Manager from 1984 to 2003, Ypsomed Holding AG in 2003, where he worked as Non-Executive Chairman from 2014 to 2022, Finox Biotech AG in 2007, where he worked as Chairman from 2007 to 2016, Fertility Biotech AG in 2016, where he worked as Chairman-Supervisory Board, and Diabetes Center Berne Foundation in 2017, where he is working as Chairman-Trustees Board from 2017.
Dr. Michel also currently works at Adval Tech Holding AG, as Honorary Chairman from 2021, Techpharma Management AG, as Chairman-Supervisory Board, BV Holding AG, as Vice Chairman from 2008, Adval Tech Holding (Germany) GmbH, as Chairman-Supervisory Board, and Faes Bau AG, as Director.
Dr. Michel also formerly worked at Disetronic Medical Systems AG, as Chairman & Chief Executive Officer in 2003, Novo Nordisk Pharma AG, as Chief Executive Officer & General Manager in 1984, Ziemer Group AG, as Director, Finox Beteiligungen AG, as Owner, and Museum Franz Gertsch, as Owner.